End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
38.33 MXN | -6.40% | -6.05% | -5.66% |
Strengths
- The company returns high margins, thereby supporting business profitability.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-5.66% | 245M | - | C+ | |
+15.55% | 81.21B | C+ | ||
-29.20% | 70.26B | B- | ||
+10.99% | 29.62B | C+ | ||
-12.02% | 16.95B | B | ||
+0.21% | 16.91B | A- | ||
-0.79% | 15.07B | A- | ||
-1.40% | 12.52B | A- | ||
+3.48% | 12.1B | B- | ||
+30.59% | 12B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- MEDICA B Stock
- Ratings Médica Sur, S.A.B. de C.V.